. Author manuscript; available in PMC: 2015 Jun 1.

Published in final edited form as: Dev Biol. 2014 Feb 26;390(1):51–67. doi: 10.1016/j.ydbio.2014.02.019

Table 2.

Summarized cell counts for Efnb2 CKO and Rbpj CKO mutant and control samples.

Strain/Stage		Control^a (mean;sd)	Mutant (mean;sd)	% change
Efnb2 CKO
E14.5(n = 12)^b	total nuclei ^c	2719; 363	2396; 338 ^*	−11.9
	Foxi1⁺ nuclei	797; 208	603; 116 ^*	−14.1
	Foxi1⁺ density^d	290; 50	255; 51	ns
E19 (n = 4)	total nuclei	7645; 1344	5842; 525	ns
	Foxi1⁺ nuclei	1942; 372	1548; 69	ns
	Foxi1⁺ density	241; 26	268; 31	ns
Rbpj CKO
E15.5 (n = 6)	total nuclei	4313; 332	1717; 158 ^**	− 60.2
	Foxi1⁺ nuclei	667; 167	575; 96	Ns
	Foxi1⁺ density	153; 31	335; 46 ^**	+ 118.4

Controls were Efnb2^+/flox or Foxg1-Cre⁺;Rbpj^+/flox

Refers to equally sized control and mutant samples

Refers to total number of DAPI⁺ nuclei within the domain of Foxi1 protein expression

Number of Foxi1⁺ nuclei per 1000 DAPI⁺ nuclei

Differences assessed by unpaired t-tests. Two-tailed values of

P < 0.05 and

^**

P < 0.0001.

Non-significance (ns) was set at P > 0.05.